A Herpesvirus saimiri-infected marmoset lymphoid cell line (MLC-1) was examined for the presence of soluble factors which might affect lymphocyte functions and, therefore, relate to the pathogenesis of lymphoma in vivo. MLC-1 cells, cell extracts, and culture fluids were shown to reduce the spontaneous deoxyribonucleic acid (DNA) synthesis of normal peripheral blood lymphocytes and to completely inhibit their response to phytohemagglutinin (PHA). Suppression of PHA response was demonstrated against a variety of human and nonhuman primate species, with 90 to 95% inhibition occurring at dilutions of extract as great as 1:5,120. Inhibition of this type was also demonstrated using extracts of two of five other lymphoblastoid cell lines tested. Physical-chemical characteristics of the active factor(s) revealed a non-sedimentable, non-dialyzable, trypsin-resistant molecule, which was stable at 56 C for 30 min but inactivated at 80 C for 30 min. The factor(s) also exerted an effect on some but not all established lymphoblastoid cell lines, where DNA, ribonucleic acid, and protein synthesis were all inhibited, with DNA synthesis being the most affected (95% suppression). Cellular respiration was not affected by the presence of the factor(s), and the inhibition of DNA synthesis was reversible after 24 h. Purified human interferon did not reduce the PHA response of normal owl monkey periperal blood lymphocytes and was less effective against an established lymphoblastoid cell line than the MLC-1 extract. Antiviral activity was also demonstrated in the preparations and may represent interferon, which these cells are known to produce at low levels.
Human peripheral blood lymphocytes (PBL) in vitro produce a variety of soluble factors upon stimulation by general mitogens or antigens. These factors may function in cell-mediated immunity in vivo and include a migration inhibitor factor (1), lymphotoxin (26) , blastogenic factor (5), chemotactic factor (23), proliferation inhibition factor (7) , and interferon (24) . Established lymphoblastoid cell lines morphologically resemble these stimulated lymphocytes (4) , have surface properties characteristic of bone marrow-derived (B-cell) or thymus-derived (T-cell) lymphocytes (15) , and produce a variety ofproducts. These factors include immunoglobulins (19) , interferon (29), migration inhibitory factor (12) , and lymphotoxin (6) . It is possible that the in vivo proliferation of lymphoblastoid tumor cells may result in the uncontrolled production of mediators of cellular immunity. This may radically alter the host's ability to initiate a specific response, which may be of significance in the development of lymphoma and contribute to tumor enhancement in vivo.
Owl monkeys (Aotus trivirgatus) infected with Herpesvirus saimiri developed lymphoma, which was frequently accompanied by a peripheral blood leukemia (3) . Diseased animals showed a depression in the response of PBL to general mitogens (22) , whereas humoral antibody titers to H. saimiri-associated antigens remained elevated (13) . In infected animals, the depression in mitogenic response was most pronounced with the T-cell mitogens phytohemagglutinin (PHA) and concanavalin A; however, reduction in the response to pokeweed mitogen was also observed (22) . This depression in mitogenic response tended to occur at the same time as, or prior to, the recovery of H. saimiri infectious centers from the peripheral blood and prior to the onset of clinical disease.
These studies suggested that the tumor cell population in vivo may be able to defend itself against normal immunological rejection by suppressing lymphocyte reactivity.
H. saimiri lymphoid tumor cells were grown in vit-ro (14, 16) , where they showed T-cell sur-face properties (21) , produced low levels of interferon (20, 28) , reacted mitogenically only to large doses of PHA, and were highly cytotoxic for certain fibroblastic cell lines in a nonspecific manner (20) (Table 3) showed that the activity was non-sedimentable (100,000 x g for 1 h) and nondialyzable. The factor(s) was relatively stable when treated at 56 C for 30 min but inactivated at 80 C for 30 min. The titer was reduced by pH 2 treatment for 18 to 20 h at 4 C. The magnitude of this reduction varied between preparations, and the actual effect of pH treatment may be obscured by protein precipitation in these crude preparations. The activity was not reduced by treatment with ribonuclease, deoxyribonuclease, or trypsin. In control studies, nuclease treatments reduced levels of acid-insoluble material by 80 to 90%, whereas trypsin treatment (15,000 U/ml for 30 min at 37 C) reduced the antiviral activity of human interferon preparations by more Studies designed to investigate the physiological effects of the MLC-1 factor(s) were conducted using cell extracts and HR-1 cells. The cally significant (P > 0.05). Levels of metabolism of both treated and untreated cultures were significantly higher than media control cultures as early as 1 h in culture.
Comparison of MLC-1 extract with purified human interferon. MLC-1 extracts completely inhibited the response of rhesus PBL to PHA with dilutions as high as 1:5,120, with a greater than 30-fold reduction in [3H]TdR incorporation being observed. Purified human interferon did not show any inhibition in PHA response to levels as high as 80,000 U/ml. Parallel titrations were performed, and MLC-1 extracts and human interferon were examined for their effects on DNA, RNA, and protein synthesis of HR-1 cells (Fig. 2) . Under the conditions em-VOL. 12, 1975 on August ployed in these experiments, DNA synthesis appeared to be the most sensitive indicator of inhibition. The dosage response of [3H]TdR incorporation to MLC-1 extract suggested that either a threshold concentration or a composite of multiple events was necessary to achieve inhibition, with 90 to 95% inhibition at dilutions of 1:320 or less. Human interferon suppressed DNA synthesis approximately 85% at 80,000 U/ml, with a gradual increase in [3H]-TdR incorporation with decreasing amounts of added interferon (Fig. 2) . RNA and protein synthesis were also inhibited by both extracts and interferon, but to lesser degrees. The effect of antimetabolites on HR-1 cells was examined and, although DNA, RNA, and protein synthesis were suppressed, the use of metabolic inhibitors mitomycin C, actinomycin D, or cyclohexamide in these assays did not suggest the manner in which the MLC-1 extract exerted its effect. Antiviral activities of cell-free MLC-1 preparations. MLC-1 cell extracts and concentrated tissue culture fluids were tested for the ability to inhibit H. saimiri or herpes simplex virus, type 1, plaque production. MLC-1 extracts (which inhibited PHA-induced DNA synthesis of lymphocytes to dilutions of 1:5,120) demonstrated little effect against H. saimiri plaque production, with 50% reduction occurring only at a 1:10 dilution with some preparations. Concentrated culture fluids were effective against H. saimiri and herpes simplex virus, type 1, at dilutions of 1:320 (Table 5) . When these fluids were treated with trypsin the antiviral activity was reduced more than 95% (Table 5) , whereas the antilymphocyte activity remained at a titer of 40. When the extract was tested against Vero cells, no reduction in [3H]TdR incorporation or no change in generation time could be detected to levels as high as 1:5 dilutions. Human interferon was 
DISCUSSION
In the present study, H. saimiri lymphoid tumor cells (MLC-1), which have T-cell surface properties, were shown to cause a suppression of mitogenic response by normal PBL. This suppression could be caused by cell-free extracts or concentrated tissue culture fluids, indicating that the inhibitory factor(s) is a product of the lymphoid tumor cells. Physical-chemical characterizations revealed a molecule similar to known soluble products of lymphoid cells. Antiviral activities were also associated with the preparations and probably represent interferon, which these cells are known to produce at low levels (20, 28) .
Inhibition of in vitro immune responses by tumor cells, cell extracts, or culture fluids from tumor cells has been reported (8, 17, 27 (8) were able to demonstrate inhibition of blastogenic responses by normal PBL. This inhibition was trypsin resistant and stable at 56 C but labile at 80 C, its action was reversible, and it was produced only under very specific conditions of crowding. Therefore, the present findings with MLC-1 cells have many features in common with other reports that indicated that tumor cells, including transformed lymphoblasts, or their products inhibited lymphocyte proliferation.
In addition to inhibitors, established lymphoblastoid cell lines release a variety of soluble products (lymphokines) into the culture medium. These factors, also produced by antigenor mitogen-stimulated PBL, differ in biological activities and sensitivities to pH, heat, and enzymatic digestion. At least three such factors have been described that demonstrate anti-cell activities: (i) lymphotoxin, a trypsin-resistant, heat-sensitive molecule which was cytotoxic for mouse L cells (9); (ii) proliferation inhibition factor, which was shown to be a heat-stable, trypsin-sensitive molecule, and inhibited the proliferation of susceptible cultures but did not affect cell viability and was reversible (7); and (iii) interferon, a heat-labile, trypsin-sensitive molecule which demonstrated antitumor cell as well as antiviral activities (25) . Thus, the factor(s) described from MLC-1 cells resembles previously described lymphokines. This molecule is heat and pH sensitive, trypsin resistant, nondialyzable, and non-sedimentable. It can reversibly inhibit lymphoid cells and has not demonstrated any inhibitory effect on Vero cells.
In owl monkeys the production of this factor might account for the depression in the response of PBL to general mitogens that is observed (22) and might contribute to the production of lymphoma. If this factor were of importance in the pathogenesis ofH. saimiri-induced lymphoma, it should be demonstrable in infected animals. Preliminary evidence suggestive of the in vivo presence of this factor(s) has been obtained. Further 
